Medical devices treating hypertension mixing arterial and venous blood: A hopeless dream
Successful treatment of hypertension is difficult despite
the availability of several classes of antihypertensive drug, and the value of
strategies to combat the effect of adverse lifestyle behaviors on blood
pressure. I have made an effort to showcase my ideas on the chronic
hypertension. There are 3 categories that need to be understood before treating
these patients.
1)
patients who are non-compliant to drug ( who do
not take drugs regularly, when taken the drug works and hypertension is
controlled)
2)
Patients who take the drug but the drug effects
have worn out ( when medications are changed they respond)
3)
Patients who do not respond to any treatment. (
approx 1in 20 are non –respondent)
The market for all three catagories is $2
B.
Mistakes made earlier by large med device
companies was to acquire the technologies without accessing the true
market.
In my opinion there are two promising
treatments to explore: 1) new pharmacological classes (such as vasopeptidase
inhibitors and aldosterone synthase inhibitors) and new molecules from present
pharmacological classes with additional properties in blood-pressure or
metabolism pathways 2) stimulation of arterial baroreceptors and catheter-based
renal denervation.


No comments:
Post a Comment